Drug establishmentActive, Registered FY2026FDA warning letter on file
Aerosol and Liquid Packaging, Inc.
Aerosol and Liquid Packaging, Inc. is an FDA-registered drug establishment (FEI 1120890) located in Baltimore, Maryland. The facility is active, registered for FY2026. Its most recent FDA inspection on record (2023-12-18) was classified OAI. FDA has issued 1 warning letter(s) to this facility.
FDA warning letter
A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.
Establishment record
Inspection history
Sep 13, 2016 · Voluntary Action Indicated (VAI)
Apr 23, 2014 · Voluntary Action Indicated (VAI)
Apr 23, 2014 · No Action Indicated (NAI)
Apr 23, 2014 · Voluntary Action Indicated (VAI)
Aug 25, 2010 · No Action Indicated (NAI)
Aug 25, 2010 · No Action Indicated (NAI)
Sep 13, 2016, 4 observations: Lack of written stability program; Training--operations, GMPs, written procedures; Procedures not in writing, fully followed
Questions
Is Aerosol and Liquid Packaging, Inc. registered with the FDA?
Yes. Aerosol and Liquid Packaging, Inc. is an FDA-registered drug establishment (FEI 1120890) in Baltimore, Maryland. Its current registration status is Active, Registered FY2026.
Has Aerosol and Liquid Packaging, Inc. received an FDA warning letter?
Yes. FDA issued a warning letter to Aerosol and Liquid Packaging, Inc.; the most recent is dated Jul 24, 2024 (CGMP/Finished Pharmaceuticals/Adulterated).
What does Aerosol and Liquid Packaging, Inc. do?
Aerosol and Liquid Packaging, Inc.'s FDA-registered operations are: Manufacturing, Relabeling, Repackaging.
Related facilities
Source: FDA public data · status as of 2026-06-06